Bard shares tick up on Q1 earnings beat

Share prices tick up for C.R. Bard after it reports a 1st-quarter earnings beat.

C.R. Bard (NYSE:BCR) shares gained today after the medical products giant reported 1st-quarter earnings that topped expectations on Wall Street, despite a poor quarterly comparison for its Lutonix drug-eluting balloon.

C.R. Bard

News Well, MassDevice.com Earnings Roundup, 2015, Drug-Eluting Balloons, Q1

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Kd7fdS